Skip to main content
. Author manuscript; available in PMC: 2024 Jun 1.
Published in final edited form as: Pediatr Blood Cancer. 2023 Mar 28;70(6):e30319. doi: 10.1002/pbc.30319

Figure 5: Association Between Participant Characteristics and Beliefs about Gene Therapy, Bone Marrow Transplantation, and Hydroxyurea as Treatment for Sickle Cell Disease Measured by Goodman and Kruskal’s Gamma coefficient (γ).

Figure 5:

The figure displays the results of an association analysis (Goodman and Kruskal’s Gamma) looking at the relationship between participant characteristics and their beliefs about gene therapy (GT), bone marrow transplant (BMT), and Hydroxyurea (HU) as interventions for Sickle Cell Disease (SCD). Significant associations are indicated with one asterisk (*) for p < 0.05 and two asterisks (**) for p < 0.001. See results for full explanation of the significant associations.